×
S&P 500   3,828.21 (+1.13%)
DOW   31,117.78 (+1.11%)
QQQ   281.20 (+0.33%)
AAPL   138.54 (+1.33%)
MSFT   259.36 (+0.99%)
META   159.82 (-0.89%)
GOOGL   2,170.65 (-0.40%)
AMZN   109.53 (+3.13%)
TSLA   677.28 (+0.57%)
NVDA   145.39 (-4.09%)
NIO   21.39 (-1.52%)
BABA   116.07 (+2.10%)
AMD   73.67 (-3.66%)
MU   53.45 (-3.31%)
CGC   2.81 (-1.40%)
T   21.37 (+1.96%)
GE   63.71 (+0.06%)
F   11.31 (+1.62%)
DIS   96.01 (+1.71%)
AMC   13.44 (-0.81%)
PFE   52.28 (-0.29%)
PYPL   71.30 (+2.09%)
NFLX   179.80 (+2.82%)
S&P 500   3,828.21 (+1.13%)
DOW   31,117.78 (+1.11%)
QQQ   281.20 (+0.33%)
AAPL   138.54 (+1.33%)
MSFT   259.36 (+0.99%)
META   159.82 (-0.89%)
GOOGL   2,170.65 (-0.40%)
AMZN   109.53 (+3.13%)
TSLA   677.28 (+0.57%)
NVDA   145.39 (-4.09%)
NIO   21.39 (-1.52%)
BABA   116.07 (+2.10%)
AMD   73.67 (-3.66%)
MU   53.45 (-3.31%)
CGC   2.81 (-1.40%)
T   21.37 (+1.96%)
GE   63.71 (+0.06%)
F   11.31 (+1.62%)
DIS   96.01 (+1.71%)
AMC   13.44 (-0.81%)
PFE   52.28 (-0.29%)
PYPL   71.30 (+2.09%)
NFLX   179.80 (+2.82%)
S&P 500   3,828.21 (+1.13%)
DOW   31,117.78 (+1.11%)
QQQ   281.20 (+0.33%)
AAPL   138.54 (+1.33%)
MSFT   259.36 (+0.99%)
META   159.82 (-0.89%)
GOOGL   2,170.65 (-0.40%)
AMZN   109.53 (+3.13%)
TSLA   677.28 (+0.57%)
NVDA   145.39 (-4.09%)
NIO   21.39 (-1.52%)
BABA   116.07 (+2.10%)
AMD   73.67 (-3.66%)
MU   53.45 (-3.31%)
CGC   2.81 (-1.40%)
T   21.37 (+1.96%)
GE   63.71 (+0.06%)
F   11.31 (+1.62%)
DIS   96.01 (+1.71%)
AMC   13.44 (-0.81%)
PFE   52.28 (-0.29%)
PYPL   71.30 (+2.09%)
NFLX   179.80 (+2.82%)
S&P 500   3,828.21 (+1.13%)
DOW   31,117.78 (+1.11%)
QQQ   281.20 (+0.33%)
AAPL   138.54 (+1.33%)
MSFT   259.36 (+0.99%)
META   159.82 (-0.89%)
GOOGL   2,170.65 (-0.40%)
AMZN   109.53 (+3.13%)
TSLA   677.28 (+0.57%)
NVDA   145.39 (-4.09%)
NIO   21.39 (-1.52%)
BABA   116.07 (+2.10%)
AMD   73.67 (-3.66%)
MU   53.45 (-3.31%)
CGC   2.81 (-1.40%)
T   21.37 (+1.96%)
GE   63.71 (+0.06%)
F   11.31 (+1.62%)
DIS   96.01 (+1.71%)
AMC   13.44 (-0.81%)
PFE   52.28 (-0.29%)
PYPL   71.30 (+2.09%)
NFLX   179.80 (+2.82%)
OTCMKTS:NUGS

Cannabis Strategic Ventures Stock Forecast, Price & News

$0.01
+0.00 (+1.48%)
(As of 06/30/2022 12:00 AM ET)
Add
Compare
Today's Range
$0.01
$0.02
50-Day Range
$0.01
$0.03
52-Week Range
$0.01
$0.08
Volume
467,451 shs
Average Volume
1.27 million shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
30 days | 90 days | 365 days | Advanced Chart

Receive NUGS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cannabis Strategic Ventures and its competitors with MarketBeat's FREE daily newsletter.

NUGS Stock Forecast (MarketRank)

Overall MarketRank

1.00 out of 5 stars

Analyst Opinion: 0.0Community Rank: 5.0Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -
Cannabis Strategic Ventures logo

About Cannabis Strategic Ventures (OTCMKTS:NUGS)

Cannabis Strategic Ventures engages in the cultivation of marijuana products in the United States. It incubates, develops, and partners within the cannabis and ancillary sectors. The company is based in Los Angeles, California.

NUGS Stock News Headlines

See More Headlines

Industry, Sector and Symbol

Industry
Drug Manufacturers-Specialty & Generic
Sub-Industry
N/A
Sector
Medical
Current Symbol
OTCMKTS:NUGS
Fax
N/A
Employees
30
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A














Cannabis Strategic Ventures Frequently Asked Questions

How has Cannabis Strategic Ventures' stock performed in 2022?

Cannabis Strategic Ventures' stock was trading at $0.0232 at the beginning of the year. Since then, NUGS stock has decreased by 40.9% and is now trading at $0.0137.
View the best growth stocks for 2022 here
.

Who are Cannabis Strategic Ventures' key executives?

Cannabis Strategic Ventures' management team includes the following people:
  • Mr. Simon Yu M.B.A., Chief Exec. Officer (Age 40)
  • Paul Hutchin, Pres
  • Ms. Arlene Guzman, VP of Operations
  • Mr. John Vu, Legal Counsel
  • J. Brown, Sec. and Director

What other stocks do shareholders of Cannabis Strategic Ventures own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Cannabis Strategic Ventures investors own include Aphria (APHA), Annovis Bio (ANVS), Amex Exploration (AMX), Amyris (AMRS), (AMPE), (ALLIF), Aleafia Health (ALEAF), Aldeyra Therapeutics (ALDX), Agraflora Organics International (AGRA) and Acreage (ACRGF).

What is Cannabis Strategic Ventures' stock symbol?

Cannabis Strategic Ventures trades on the OTCMKTS under the ticker symbol "NUGS."

How do I buy shares of Cannabis Strategic Ventures?

Shares of NUGS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Cannabis Strategic Ventures' stock price today?

One share of NUGS stock can currently be purchased for approximately $0.01.

How many employees does Cannabis Strategic Ventures have?

Cannabis Strategic Ventures employs 30 workers across the globe.

How can I contact Cannabis Strategic Ventures?

Cannabis Strategic Ventures' mailing address is 833 S Spring St Ste 202, Los Angeles, California 90014-2964. The official website for Cannabis Strategic Ventures is www.cannabisstrategic.com. The company can be reached via phone at (310) 359-6860.

This page (OTCMKTS:NUGS) was last updated on 7/1/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer.